| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 05/23/2001 | EP1100790A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |
| 05/23/2001 | EP1100783A1 Improved method for producing 2-halopyridine-n-oxide |
| 05/23/2001 | EP1100775A2 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same |
| 05/23/2001 | EP1100774A1 Improved arylamine synthesis |
| 05/23/2001 | EP1100766A1 Crosslinkable liquid crystalline compounds |
| 05/23/2001 | EP1100763A1 Diketoacid-derivatives as inhibitors of polymerases |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/23/2001 | EP1100506A1 Integrin receptor antagonists |
| 05/23/2001 | EP1100503A2 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 05/23/2001 | EP0689536B1 Naphthalene derivatives |
| 05/23/2001 | CN1296477A Piperazine derivatives and process for the preparation thereof |
| 05/23/2001 | CN1296476A Synthesis of 1-(2-sulphoethyl)-pyridinium betaine |
| 05/23/2001 | CN1296004A Method for producing nicotinic acid |
| 05/23/2001 | CN1066133C Substituted (hetero) aryl compounds, process for preparation, agents containing them, and their use |
| 05/22/2001 | US6235936 Transition metal catalyst for arylation |
| 05/22/2001 | US6235909 Preparation of is-[1A,2B,3B,4A(S*)]-4-[7-[[1-(3-chloro-2-Thienyl)methyl]amino]-3H-imidazo [4,5-B]pyridin-3-YL]-N-ethyl-2,3-dihydroxycyclopentanecarboxamide |
| 05/22/2001 | US6235907 Intermediates useful in making mappicine and related compounds |
| 05/22/2001 | US6235790 Hydroxamic-acid derivatives, method of preparing them and their use as fungicides |
| 05/22/2001 | US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis |
| 05/22/2001 | US6235778 Anticoagulants |
| 05/22/2001 | US6235768 Osteoporosis; rheumatic disorders; antitumor agents |
| 05/22/2001 | US6235761 Compound, composition and method for treating cancer |
| 05/22/2001 | US6235750 Nitric oxide synthase inhibitor |
| 05/22/2001 | US6235747 6-phenyl-pyridin-2-ylamine derivatives |
| 05/22/2001 | US6235744 Synergistic mixture |
| 05/22/2001 | US6235736 3-anilino-2-cycloalkenone derivatives |
| 05/22/2001 | US6235732 Neurokinin antagonists |
| 05/22/2001 | US6235509 Process for inhibiting serine proteases using cresol or 3-hydroxypyridine and sulfonic acid derivatives or fluorophosphonates |
| 05/17/2001 | WO2001034602A2 Process and intermediates for the preparation of imidazolidinone alpha v integrin antagonists |
| 05/17/2001 | WO2001034579A1 Alkoxyiminoalkanoic acid derivatives |
| 05/17/2001 | WO2001034573A1 Compounds |
| 05/17/2001 | WO2001034569A1 Pancreatitis remedies |
| 05/17/2001 | WO2001034568A1 Oxime o-ether compounds and fungicides for agricultural and horticultural use |
| 05/17/2001 | WO2000076457A3 Il-8 receptor antagonists |
| 05/17/2001 | CA2390928A1 Alkoxyiminoalkanoic acid derivatives |
| 05/17/2001 | CA2389999A1 Process and intermediates for the preparation of imidazolidinone alpha v integrin antagonists |
| 05/17/2001 | CA2389805A1 Oxime o-ether compounds and fungicides for agricultural and horticultural use |
| 05/16/2001 | EP1099714A1 Polymerisation catalyst |
| 05/16/2001 | EP1099693A1 Radiolabelled peptide compounds |
| 05/16/2001 | EP1099692A1 N,n-substituted cyclic amine derivatives |
| 05/16/2001 | EP1098881A1 3-substituted pyridine compounds and related synthesis |
| 05/16/2001 | EP1098880A1 Dechlorination of pyridines in acidic, zinc-containing mediums |
| 05/16/2001 | EP1098879A1 Processes for producing highly pure nicotinamide |
| 05/16/2001 | EP1098874A1 Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments |
| 05/16/2001 | EP1098870A2 Nitric esters and nitrate salts of specific drugs |
| 05/16/2001 | EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 05/16/2001 | EP1098647A1 Compounds and compositions for treating tissue ischemia |
| 05/16/2001 | EP1070041A4 Phosphate-mediated cyclization |
| 05/16/2001 | EP1039886A4 Hiv/fiv protease inhibitors having a small p3 residue |
| 05/16/2001 | EP0882719B1 Arylethenesulfonamide derivatives and drug composition containing the same |
| 05/16/2001 | CN1295570A N-pyriconyl herbicides |
| 05/16/2001 | CN1295548A Novel tricyclic compound |
| 05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
| 05/16/2001 | CN1295072A New polycyclic system compound as neurotransmitter release reinforcer in treatment of identification fault and derivatives thereof |
| 05/16/2001 | CN1295066A Malonate derivative, its prep. and use |
| 05/16/2001 | CN1065861C Phenyl substituted alkenocarboxylic guanidine, preparation method application as medicine or diagnostic agent and medicine containing it |
| 05/15/2001 | US6232342 Protease inhibitors |
| 05/15/2001 | US6232328 Non-systemic control of parasites |
| 05/15/2001 | US6232321 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 05/15/2001 | US6232316 Such as parkinson's disease, tourette's syndrome, schizophrenia, and senile dementia of alzheimers disease |
| 05/15/2001 | US6232314 Arylalkylpiperazine compounds as antioxidants |
| 05/15/2001 | US6232118 Nucleic acid encoding a protein of defined amino acid sequence; recombinant cell culture production; diagnosis; probes; treatment of parkinson's disease and other nervous system disorders with reduced side effects; gene therapy |
| 05/15/2001 | US6232057 Achieving enhanced sensitivity and reduced fog using iodide ion releasing compound which can release the iodide ion rapidly. |
| 05/10/2001 | WO2001032623A1 An activated-thiol polymer for drug delivery |
| 05/10/2001 | WO2001032611A1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 05/10/2001 | WO2001032604A1 Activators of soluble guanylate cyclase |
| 05/10/2001 | WO2001032264A1 Aryl olefinic azacyclic, and aryl acetylenic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| 05/10/2001 | WO2001017959A3 Vitronectin receptor antagonists |
| 05/10/2001 | WO2000077035A3 Novel potassium channels and genes encoding these potassium channels |
| 05/10/2001 | WO2000073276A3 Carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists |
| 05/10/2001 | US20010000889 Processes for electrically activated transformation of chemical and material compositions |
| 05/10/2001 | CA2389773A1 Activators of soluble guanylate cyclase |
| 05/10/2001 | CA2389645A1 Aryl olefinic azacyclic, and aryl acetylenic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| 05/09/2001 | EP1097925A1 Novel benzoic acid derivatives and processes for the preparation thereof |
| 05/09/2001 | EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097707A1 Treatment of female sexual dysfunction |
| 05/09/2001 | EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097158A2 Ligands for metals and metal-catalyzed processes |
| 05/09/2001 | EP1097129A1 N-benzocycloalkyl-amide derivatives and their use as medicaments |
| 05/09/2001 | EP1097117A2 Aryl vinyl ether derivatives and their use as herbicides |
| 05/09/2001 | CN1294581A Pyridine derivative and pharmaceutical contg. same |
| 05/09/2001 | CN1294577A 钾通道抑制剂 Potassium channel inhibitors |
| 05/09/2001 | CN1293896A Antifungal active compound compsns. |
| 05/09/2001 | CN1293893A Antifungal active compound compsns. |
| 05/09/2001 | CN1065559C Photo-cross-linkable optically active compounds |
| 05/08/2001 | US6229018 Process for the preparation of nicotinic acid |
| 05/08/2001 | US6229016 Method for treating tumors using 2-aryl-naphthyridin-4-ones |
| 05/08/2001 | US6229011 N-aroylphenylalanine derivative VCAM-1 inhibitors |
| 05/08/2001 | US6228942 Dehydration to esterify or amidate surface of oxidized or aminated carbon powder or fiber suspended in solution containing a monomer or polymer having amine, hydroxy, and/or viny ether groups |
| 05/08/2001 | US6228858 2,5-methylol-3,6-(aminomethyl)-hydroquinone; diabetes nephropathy; controlling blood sugar |
| 05/08/2001 | US6228848 3-(1-propen-3-oxo)-5,6-dihydronaphthalene derivatives; side effect reduction |
| 05/08/2001 | US6228810 Outstanding efficacy against broad spectrum of phytopathogenic fungi; effective control of pests from classes of insects, arachnids and nematodes |
| 05/08/2001 | CA2324484A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323464A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323191A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323183A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2016620C Process for the preparation of 3,5,6-trichloropyridin-2-ol |
| 05/03/2001 | WO2001030790A1 Half-sandwich ruthenium (ii) compounds comprising nitrogen containing ligands for treatment of cancer |
| 05/03/2001 | WO2001030749A1 Novel compounds |